4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BA1
The NM_001388492.1(HTT):c.105_110delGCAGCA(p.Gln36_Gln37del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.245 in 1,348,998 control chromosomes in the GnomAD database, including 35,626 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.20 ( 3269 hom., cov: 0)
Exomes 𝑓: 0.25 ( 32357 hom. )
Consequence
HTT
NM_001388492.1 disruptive_inframe_deletion
NM_001388492.1 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.65
Publications
6 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-CCAGCAG-C is Benign according to our data. Variant chr4-3074876-CCAGCAG-C is described in ClinVar as [Likely_benign]. Clinvar id is 1328024.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTT | NM_001388492.1 | c.105_110delGCAGCA | p.Gln36_Gln37del | disruptive_inframe_deletion | Exon 1 of 67 | ENST00000355072.11 | NP_001375421.1 | |
HTT | NM_002111.8 | c.105_110delGCAGCA | p.Gln36_Gln37del | disruptive_inframe_deletion | Exon 1 of 67 | NP_002102.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.203 AC: 26654AN: 131118Hom.: 3269 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
26654
AN:
131118
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.249 AC: 303610AN: 1217784Hom.: 32357 AF XY: 0.252 AC XY: 152292AN XY: 603946 show subpopulations
GnomAD4 exome
AF:
AC:
303610
AN:
1217784
Hom.:
AF XY:
AC XY:
152292
AN XY:
603946
show subpopulations
African (AFR)
AF:
AC:
3112
AN:
25688
American (AMR)
AF:
AC:
6327
AN:
29842
Ashkenazi Jewish (ASJ)
AF:
AC:
6121
AN:
22568
East Asian (EAS)
AF:
AC:
8890
AN:
28388
South Asian (SAS)
AF:
AC:
26050
AN:
71538
European-Finnish (FIN)
AF:
AC:
5622
AN:
31932
Middle Eastern (MID)
AF:
AC:
991
AN:
3758
European-Non Finnish (NFE)
AF:
AC:
233808
AN:
952614
Other (OTH)
AF:
AC:
12689
AN:
51456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
8671
17342
26012
34683
43354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.203 AC: 26660AN: 131214Hom.: 3269 Cov.: 0 AF XY: 0.206 AC XY: 13028AN XY: 63102 show subpopulations
GnomAD4 genome
AF:
AC:
26660
AN:
131214
Hom.:
Cov.:
0
AF XY:
AC XY:
13028
AN XY:
63102
show subpopulations
African (AFR)
AF:
AC:
4137
AN:
35462
American (AMR)
AF:
AC:
2641
AN:
13360
Ashkenazi Jewish (ASJ)
AF:
AC:
930
AN:
3174
East Asian (EAS)
AF:
AC:
1291
AN:
4092
South Asian (SAS)
AF:
AC:
1610
AN:
3900
European-Finnish (FIN)
AF:
AC:
1288
AN:
7324
Middle Eastern (MID)
AF:
AC:
93
AN:
252
European-Non Finnish (NFE)
AF:
AC:
13923
AN:
61058
Other (OTH)
AF:
AC:
401
AN:
1802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
819
1637
2456
3274
4093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not specified Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.